AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16563423 — intervention group
Group type: EXPERIMENTAL
Intervention: Memorability-based training
Number of subjects: 142
Study 16563423 — intervention group
Group type: EXPERIMENTAL
Intervention: Source-monitoring training
Number of subjects: 142
Study 16563423 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 142
Study 16563423 — intervention group
Group type: EXPERIMENTAL
Intervention: Memorability-based training (older children)
Number of subjects: 142
Study 16563423 — intervention group
Group type: EXPERIMENTAL
Intervention: Source-monitoring training (older children)
Number of subjects: 142
Study 16563423 — intervention group
Group type: COMPARATOR
Intervention: No training (older children)
Number of subjects: 142
Study 10551636 — intervention group
Group type: EXPERIMENTAL
Intervention: SDZ-RAD (RAD) 0.75 mg/day, 2.5 mg/day, or 7.5 mg/day for 4 weeks
Number of subjects: 0
Study 10551636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8565028 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 17
Study 8565028 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 17
Study 1743250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 5 mg.kg‐1
Number of subjects: 0
Study 1743250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 15 mg.kg‐1
Number of subjects: 0
Study 1743250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 30 mg.kg‐1
Number of subjects: 0
Study 1743250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil 5 mg.kg‐1 with Cephalexin 45 mg.kg‐1
Number of subjects: 0
Study 6790688 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nasogastric feeding
Number of subjects: 11
Study 6790688 — intervention group
Group type: COMPARATOR
Intervention: Intermittent oral feeding
Number of subjects: 11
Study 29654364 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic induction task
Number of subjects: 0
Study 29654364 — intervention group
Group type: COMPARATOR
Intervention: Perceptual induction task
Number of subjects: 0
Study 29309486 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12 mg ranibizumab
Number of subjects: 19
Study 29309486 — intervention group
Group type: COMPARATOR
Intervention: 0.20 mg ranibizumab
Number of subjects: 19
Study 25791743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural strategies with exercise
Number of subjects: 75
Study 25791743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural strategies without exercise
Number of subjects: 75
Study 25791743 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 75
Study 24992844 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine (CHX)
Number of subjects: 60
Study 24992844 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% povidone iodine (PI)
Number of subjects: 60
Study 24992844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (OZ)
Number of subjects: 60
Study 21762355 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion cysts (single/multiple anechoic ≤10‐mm ovarian cysts)
Number of subjects: 48230
Study 21762355 — intervention group
Group type: COMPARATOR
Intervention: Normal ovaries
Number of subjects: 48230
Study 20976384 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine enamel
Number of subjects: 14
Study 20976384 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine root dentin
Number of subjects: 14
Study 17344493 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-glycemic-load (RGL) diet
Number of subjects: 86
Study 17344493 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, portion-controlled diet (Control)
Number of subjects: 86
Study 16261949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761
Number of subjects: 683
Study 16261949 — intervention group
Group type: COMPARATOR
Intervention: Standard cohort (control)
Number of subjects: 683
Study 16261949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo cohort
Number of subjects: 683
Study 11906804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (600-900 mg daily)
Number of subjects: 39
Study 11906804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 11906804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 39
Study 10460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract
Number of subjects: 60
Study 10460963 — intervention group
Group type: COMPARATOR
Intervention: Tytin
Number of subjects: 60
Study 7602349 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour infusion of paclitaxel at 200 mg/m2
Number of subjects: 59
Study 7602349 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour infusion of paclitaxel at 135 mg/m2
Number of subjects: 59
Study 7602349 — intervention group
Group type: COMPARATOR
Intervention: 1-hour infusion of paclitaxel (both 1-day and 3-day schedules)
Number of subjects: 59
Study 7602349 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour infusion of paclitaxel (both doses)
Number of subjects: 59
Study 2367614 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 66
Study 2367614 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 66
Study 2367614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 30848096 — intervention group
Group type: EXPERIMENTAL
Intervention: 31 g of milk protein supplementation for 12 weeks
Number of subjects: 116
Study 30848096 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric placebo supplementation for 12 weeks
Number of subjects: 116
Study 28719996 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted mobilization (30 minutes using Gloreha device)
Number of subjects: 32
Study 28719996 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted mobilization
Number of subjects: 32
Study 28719996 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 minutes additional PT and OT for 3 weeks)
Number of subjects: 32
Study 26826565 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Temperature Management (TTM) at 33 °C
Number of subjects: 169
Study 26826565 — intervention group
Group type: COMPARATOR
Intervention: Target Temperature Management (TTM) at 36 °C
Number of subjects: 169
Study 26826565 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MBL levels
Number of subjects: 169
Study 26826565 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MAp44 levels
Number of subjects: 169
Study 24628042 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with modified glucose‐insulin‐potassium solution targeting glucose levels of 4.4‐8.3 mmol/l
Number of subjects: 199
Study 24628042 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment targeting glucose levels of < 13.8 mmol/l
Number of subjects: 199
Study 24628042 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 199
Study 24628042 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 199
Study 24628042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 199
Study 22128076 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral cyclophosphamide (DO)
Number of subjects: 148
Study 22128076 — intervention group
Group type: COMPARATOR
Intervention: Pulse cyclophosphamide
Number of subjects: 148
Study 20388444 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) daily with radiotherapy
Number of subjects: 60
Study 20388444 — intervention group
Group type: COMPARATOR
Intervention: Standard mouth care only (Control)
Number of subjects: 60
Study 17452695 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24 microg (12+12) via Aerolizer
Number of subjects: 60
Study 17452695 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 600 microg (200+200+200) via meter-dose inhaler
Number of subjects: 60
Study 17452695 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Formoterol vs Salbutamol
Number of subjects: 60
Study 17452695 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 60
Study 15149786 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine strain S. typhi Ty21a (pDB1) expressing subunits A and B of recombinant Helicobacter pylori urease (n = 9)
Number of subjects: 13
Study 15149786 — intervention group
Group type: COMPARATOR
Intervention: Placebo strain S. typhi Ty21a (n = 4)
Number of subjects: 13
Study 15149786 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine strain S. typhi Ty21a (pDB1) (n = 9)
Number of subjects: 13
Study 12429052 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human GH
Number of subjects: 17
Study 9667709 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin staples for securing the mesh
Number of subjects: 50
Study 9667709 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene sutures for securing the mesh (Control)
Number of subjects: 50
Study 8599745 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (5g four times per day for five days)
Number of subjects: 20
Study 8599745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2800988 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of EMLA cream
Number of subjects: 0
Study 405998 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sodium cromoglycate ointment
Number of subjects: 21
Study 405998 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment (white soft-paraffin base only)
Number of subjects: 21
Study 31584682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care coordination through the CHECK program (n=3126)
Number of subjects: 6259
Study 31584682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=3119)
Number of subjects: 6259
Study 31584682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care coordination through the CHECK program
Number of subjects: 6259
Study 31584682 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6259
Study 31584682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care coordination through the CHECK program (participants with asthma)
Number of subjects: 6259
Study 31584682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (participants with asthma)
Number of subjects: 6259
Study 31584682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care coordination through the CHECK program (participants with sickle cell disease)
Number of subjects: 6259
Study 31584682 — intervention group
Group type: COMPARATOR
Intervention: Usual care (participants with sickle cell disease)
Number of subjects: 6259
Study 29037063 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (5000 or 50,000 IUs weekly) for depression treatment
Number of subjects: 21
Study 25495266 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to cautionary tales (positive/negative conditions)
Number of subjects: 305
Study 25495266 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exposure to cautionary tales)
Number of subjects: 305
Study 23302976 — intervention group
Group type: EXPERIMENTAL
Intervention: Volitionally delayed reporting of AWR
Number of subjects: 0
Study 23302976 — intervention group
Group type: COMPARATOR
Intervention: Preoperative education and structured postoperative interviews
Number of subjects: 0
Study 21107534 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated intervention program (MTF group)
Number of subjects: 403
Study 21107534 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 403
Study 21107534 — intervention group
Group type: COMPARATOR
Intervention: Control group vs Intervention group
Number of subjects: 403
Study 18553033 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepid sponging plus dipyrone (20 mg/kg) for 15 minutes
Number of subjects: 120
Study 18553033 — intervention group
Group type: COMPARATOR
Intervention: Dipyrone alone (20 mg/kg)
Number of subjects: 120
Study 15724045 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg elemental zinc supplementation
Number of subjects: 0
Study 15724045 — intervention group
Group type: COMPARATOR
Intervention: Oral placebos
Number of subjects: 0
Study 11819193 — intervention group
Group type: EXPERIMENTAL
Intervention: Double caudal injection of bupivacaine (0.5 mL kg(‐1) on each occasion) at the end of surgery with unstented Thiersch‐Duplay repair (group 5)
Number of subjects: 160
Study 11819193 — intervention group
Group type: EXPERIMENTAL
Intervention: Double caudal injection of bupivacaine (0.5 mL kg(‐1) on each occasion) at the end of surgery with stented Mathieu type repair (group 6)
Number of subjects: 160
Study 11819193 — intervention group
Group type: COMPARATOR
Intervention: Single caudal injection of 1 mL kg(‐1) of 0.25% plain bupivacaine at the start of surgery with unstented Thiersh‐Duplay repair (group 3)
Number of subjects: 160
Study 11819193 — intervention group
Group type: COMPARATOR
Intervention: Single caudal injection of 1 mL kg(‐1) of 0.25% plain bupivacaine at the start of surgery with stented Mathieu type repair (group 4)
Number of subjects: 160
Study 11819193 — intervention group
Group type: COMPARATOR
Intervention: Double caudal injection versus single caudal injection
Number of subjects: 160
Study 10029962 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated Electronic Dental Anesthesia (AEDA)
Number of subjects: 30
Study 10029962 — intervention group
Group type: COMPARATOR
Intervention: Nonactive Electronic Dental Anesthesia (NAEDA)
Number of subjects: 30
Study 7574780 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR‐CH (10 mg/person local injection)
Number of subjects: 0
Study 7574780 — intervention group
Group type: COMPARATOR
Intervention: ACR aqueous solution (10 mg/person local injection)
Number of subjects: 0
Study 2185157 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone at six times the MIC
Number of subjects: 33
Study 2185157 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone at 1 mg/l
Number of subjects: 33
Study 2185157 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin alone or in combination with chloramphenicol
Number of subjects: 33
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes open with lighted +20‐diopter lenses
Number of subjects: 20
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes open with lighted +20‐diopter lenses plus strobe lighting
Number of subjects: 20
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes open in darkness
Number of subjects: 20
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes closed in darkness
Number of subjects: 20
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes closed in a dimly lighted room
Number of subjects: 20
Study 7396793 — intervention group
Group type: EXPERIMENTAL
Intervention: eyes open with unlighted +20‐diopter lenses plus strobe lighting
Number of subjects: 20
Study 30060248 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of CKA up to 600 mg in humans
Number of subjects: 0
Study 30060248 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of CKA in rats
Number of subjects: 0
Study 26831629 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Conditioned Plasma (ACP) injections
Number of subjects: 30
Study 26831629 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30
Study 25603442 — intervention group
Group type: EXPERIMENTAL
Intervention: Motorized diamond burr polishing
Number of subjects: 40
Study 25603442 — intervention group
Group type: COMPARATOR
Intervention: Manual polishing
Number of subjects: 40
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: BOC plus PegIFN/RBV for 44 weeks (BOC/PR48)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus PegIFN/RBV for 44 weeks (PR48)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: BOC plus PegIFN/RBV using response-guided therapy (BOC/RGT)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of anemia (EPO without RBV dose reduction)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of anemia (RBV dose reduction without EPO)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of anemia (EPO with RBV dose reduction)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of anemia (neither RBV dose reduction nor EPO)
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patients with anemia
Number of subjects: 1097
Study 23081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious and life-threatening adverse events (AEs) among BOC-treated patients
Number of subjects: 1097
Study 20846082 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic ASQ (asthma screening questionnaire) using a tablet computer
Number of subjects: 48
Study 20846082 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil ASQ
Number of subjects: 48
Study 18992654 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tolvaptan, a vasopressin antagonist
Number of subjects: 4133
Study 18992654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4133
Study 18992654 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tolvaptan
Number of subjects: 4133
Study 16826475 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine-pyrimethamine (SP)
Number of subjects: 0
Study 16826475 — intervention group
Group type: COMPARATOR
Intervention: 2-dose sulfadoxine-pyrimethamine (SP)
Number of subjects: 0
Study 16826475 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study 15253884 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated fish oil (3g/day, equivalent to 1g/day of n‐3 PUFA) for 6 months
Number of subjects: 65
Study 15253884 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (3g/day) as placebo
Number of subjects: 65
Study 11251496 — intervention group
Group type: EXPERIMENTAL
Intervention: Team midwife care
Number of subjects: 1000
Study 11251496 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000
Study 9071199 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 90
Study 9071199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg tid)
Number of subjects: 90
Study 8220974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fan beam DXA scans (Hologic QDR-2000)
Number of subjects: 20
Study 8220974 — intervention group
Group type: COMPARATOR
Intervention: Pencil beam DXA scans (Hologic QDR-1000)
Number of subjects: 20
Study 8220974 — intervention group
Group type: COMPARATOR
Intervention: Comparison of fan beam and pencil beam data
Number of subjects: 20
Study 8220974 — intervention group
Group type: COMPARATOR
Intervention: Fan beam vs. pencil beam for AREA and BMC
Number of subjects: 20
Study 8220974 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall effect on BMD measurements
Number of subjects: 20
Study 3098273 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 21
Study 3098273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 29107036 — intervention group
Group type: EXPERIMENTAL
Intervention: BA+CPT (Behavioral Activation + Cognitive Processing Therapy)
Number of subjects: 0
Study 29107036 — intervention group
Group type: COMPARATOR
Intervention: CPT (Cognitive Processing Therapy)
Number of subjects: 0
Study 27087678 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) integrated with a self-administered stretching program
Number of subjects: 31
Study 27087678 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study 24886671 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX chemotherapy strategy
Number of subjects: 620
Study 22697270 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic nerve head morphology evaluation
Number of subjects: 246
Study 22697270 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field performance evaluation
Number of subjects: 246
Study 20381576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral digital impressions (Lava C.O.S.)
Number of subjects: 20
Study 20381576 — intervention group
Group type: COMPARATOR
Intervention: Silicone impressions
Number of subjects: 20
Study 19378437 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone treatment
Number of subjects: 26
Study 19378437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 15978154 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars Flaccida (PF) pathway
Number of subjects: 202
Study 15978154 — intervention group
Group type: COMPARATOR
Intervention: Perigastric (PG) pathway
Number of subjects: 202
Study 12708105 — intervention group
Group type: EXPERIMENTAL
Intervention: Order of testing (OT tests first or PT tests first) for volunteers
Number of subjects: 167
Study 12708105 — intervention group
Group type: COMPARATOR
Intervention: Patients undergoing a multidisciplinary Spine Team Assessment
Number of subjects: 167
Study 10807146 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening (FS)
Number of subjects: 4422
Study 8868311 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion (0.3 microgram/kg/min)
Number of subjects: 18
Study 8868311 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (50 ml isotonic saline)
Number of subjects: 18
Study 1364939 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric coated granules
Number of subjects: 16
Study 1364939 — intervention group
Group type: COMPARATOR
Intervention: Plain tablets
Number of subjects: 16
Study 4019267 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms sodium selenate
Number of subjects: 0
Study 4019267 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms sodium selenate together with 200 mg ascorbic acid
Number of subjects: 0
Study 4019267 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ascorbic acid three times daily during meals
Number of subjects: 0
Study 4019267 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma GSH‐Px activity
Number of subjects: 0